SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-19-010465
Filing Date
2019-08-08
Accepted
2019-08-08 16:24:20
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cerc10-q20190630.htm 10-Q 1456223
2 EXHIBIT 31.1 q22019cercex-311.htm EX-31.1 15880
3 EXHIBIT 32.1 q22019cercex-321.htm EX-32.1 10140
10 productpipelineassetchart811.jpg GRAPHIC 172030
11 rdupcomingmilestonechart8119.jpg GRAPHIC 149692
  Complete submission text file 0001628280-19-010465.txt   9225603

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT cerc-20190630.xml EX-101.INS 1822312
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20190630.xsd EX-101.SCH 65924
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20190630_cal.xml EX-101.CAL 93751
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20190630_def.xml EX-101.DEF 437812
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20190630_lab.xml EX-101.LAB 892237
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20190630_pre.xml EX-101.PRE 559736
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 191009933
SIC: 2834 Pharmaceutical Preparations